Evidence map›Paper›PMID 32008935›Full record

ArticleMedical engineering & physics2020

A novel 3D-Printed preferential posterior mitral annular dilation device delineates regurgitation onset threshold in an ex vivo heart simulator.

Annabel M Imbrie-Moore, Cole C Paullin, Michael J Paulsen, Frederick Grady, Hanjay Wang, Camille E Hironaka, Justin M Farry, Haley J Lucian, Y Joseph Woo

Open access · greenAbstract read
In one paragraph

Article in Medical engineering & physics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Repairable ex vivo model of functional and degenerative mitral regurgitation.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2023
    Article
  3. Article
  4. Article
  5. Artificial papillary muscle device for off-pump transapical mitral valve repair.The Journal of thoracic and cardiovascular surgery · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Commentary: Valvular mimicry in simulation-espice, adspice, prospice.The Journal of thoracic and cardiovascular surgery · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Annabel M Imbrie-MooreDepartment of Cardiothoracic Surgery, Stanford University, Stanford, CA; Department of Mechanical Engineering, Stanford University, Stanford, CA.
Cole C PaullinDepartment of Mechanical Engineering, Stanford University, Stanford, CA.
Michael J PaulsenDepartment of Cardiothoracic Surgery, Stanford University, Stanford, CA.
Frederick GradyDepartment of Cardiothoracic Surgery, Stanford University, Stanford, CA; Meharry Medical College, Nashville, TN.
Hanjay WangDepartment of Cardiothoracic Surgery, Stanford University, Stanford, CA.
Camille E HironakaDepartment of Cardiothoracic Surgery, Stanford University, Stanford, CA.
Justin M FarryDepartment of Cardiothoracic Surgery, Stanford University, Stanford, CA.
Haley J LucianDepartment of Cardiothoracic Surgery, Stanford University, Stanford, CA.
Y Joseph WooDepartment of Cardiothoracic Surgery, Stanford University, Stanford, CA; Department of Bioengineering, Stanford University, Stanford, CA. Electronic address: joswoo@stanford.edu.
Stanford University · USMeharry Medical College · US

Funding

ANGIOGENIC TISSUE ENGINEERING TO LIMIT POST-INFARCTION VENTRICULAR REMODELINGR01HL089315 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI WOO, Y JOSEPH · 2008 to 2023
$6.4M
Biomechanical Optimization of Mitral Valve Repair OperationsR01HL152155 · NHLBI · STANFORD UNIVERSITY · PI WOO, Y JOSEPH · 2020 to 2025
$5.9M
NHLBI NIH HHS R01 HL089315NHLBI NIH HHS R01 HL152155
6 · The paper itself

Abstract

Mitral regurgitation (MR) due to annular dilation occurs in a variety of mitral valve diseases and is observed in many patients with heart failure due to mitral regurgitation. To understand the biomechanics of MR and ultimately design an optimized annuloplasty ring, a representative disease model with asymmetric dilation of the mitral annulus is needed. This work shows the design and implementation of a 3D-printed valve dilation device to preferentially dilate the posterior mitral valve annulus. Porcine mitral valves (n = 3) were sewn into the device and mounted within a left heart simulator that generates physiologic pressures and flows through the valves, while chordal forces were measured. The valves were incrementally dilated, inducing MR, while hemodynamic and force data were collected. Flow analysis demonstrated that MR increased linearly with respect to percent annular dilation when dilation was greater than a 25.6% dilation threshold (p < 0.01). Pre-threshold, dilation did not cause significant increases in regurgitant fraction. Forces on the chordae tendineae increased as dilation increased prior to the identified threshold (p < 0.01); post-threshold, the MR resulted in highly variable forces. Ultimately, this novel dilation device can be used to more accurately model a wide range of MR disease states and their corresponding repair techniques using ex vivo experimentation. In particular, this annular dilation device provides the means to investigate the design and optimization of novel annuloplasty rings.

Indexed as

Printing, Three-DimensionalAnimalsDilatationEquipment DesignHemodynamicsMitral Valve InsufficiencySwineCardiac biomechanicsDisease modelsEx vivo experimentationMedical devices

Identifiers

PMID32008935
PMCPMC8315587
OpenAlexW3004087171

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.